Physician profile
Steffen E Carey
NPI 1659660215
$724.86
in general payments reported to CMS, 2019-2025
23 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $102 · 2021: $119 · 2022: $85.09 · 2023: $104 · 2024: $90.59 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $84.89 | 2019-2024 | |
| Glaxosmithkline, LLC. | $69.08 | 2019-2023 | Shingrix, Trelegy Ellipta, Arexvy |
| Amgen INC. | $67.13 | 2020-2025 | Evenity |
| Astrazeneca Pharmaceuticals LP | $52.32 | 2019-2020 | |
| Gilead Sciences, INC. | $49.11 | 2021-2024 | Epclusa |
| Biohaven Pharmaceuticals, INC. | $46.84 | 2021 | |
| Exact Sciences Corporation | $43.75 | 2023-2025 | Cologuard Collection Kit |
| Insulet Corporation | $41.43 | 2022 | |
| Janssen Pharmaceuticals, INC | $24.46 | 2021 | |
| Hologic Sales and Service, LLC | $23.24 | 2024 | Thinprep 2000 Processor, Aptima |
| Pharmacosmos Therapeutics INC. | $22.36 | 2023 | Monoferric |
| Abbvie INC. | $21.62 | 2025 | |
| Inspire Medical Systems, INC. | $20.05 | 2025 | Inspire |
| Cranial Technologies, INC | $18.77 | 2025 | Doc Band |
| Bayer Healthcare Pharmaceuticals INC. | $17.20 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $16.92 | 2024 | Dexcom G6 Transmitter |
| Melinta Therapeutics, LLC | $16.73 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.20 | 2020 | |
| Merck Sharp & Dohme LLC | $15.49 | 2023 | Rotateq, Vaxelis, Vaqta |
| Genentech USA, INC. | $15.10 | 2019 | |
| Novo Nordisk INC | $14.43 | 2022 | |
| Allergan, INC. | $13.88 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steffen Carey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.